Matches in Nanopublications for { ?s ?p "[Increased CF6 may be responsible in part for decreased prostacyclin observed in coronary heart disease, in particular after PTCA and stent therapy/risk factor for coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP131414.RADNbR4KucCC8yTiRsj88KxMiy-XBVfwu8D0Jm2RNGZn0130_assertion description "[Increased CF6 may be responsible in part for decreased prostacyclin observed in coronary heart disease, in particular after PTCA and stent therapy/risk factor for coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131414.RADNbR4KucCC8yTiRsj88KxMiy-XBVfwu8D0Jm2RNGZn0130_provenance.
- assertion description "[Increased CF6 may be responsible in part for decreased prostacyclin observed in coronary heart disease, in particular after PTCA and stent therapy/risk factor for coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP131436.RA0MnbWIVgPIKt_mvnsjmMQdai_p-mqNKlh0ECzkuUSmI130_assertion description "[Increased CF6 may be responsible in part for decreased prostacyclin observed in coronary heart disease, in particular after PTCA and stent therapy/risk factor for coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131436.RA0MnbWIVgPIKt_mvnsjmMQdai_p-mqNKlh0ECzkuUSmI130_provenance.
- NP224565.RAAekEq_m40jEMabrYIJ-egkJwDuoCf1-sndhs7V0iFNI130_assertion description "[Increased CF6 may be responsible in part for decreased prostacyclin observed in coronary heart disease, in particular after PTCA and stent therapy/risk factor for coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224565.RAAekEq_m40jEMabrYIJ-egkJwDuoCf1-sndhs7V0iFNI130_provenance.
- NP194607.RA5rpSLwbAuvFxVukx1ivXaC1NbmPK-MrJcdyCuDbRnX0130_assertion description "[Increased CF6 may be responsible in part for decreased prostacyclin observed in coronary heart disease, in particular after PTCA and stent therapy/risk factor for coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194607.RA5rpSLwbAuvFxVukx1ivXaC1NbmPK-MrJcdyCuDbRnX0130_provenance.
- NP194585.RAFwuqVAXnC8gMp0_73hpiSy_C2QZ-CUS2KCflkdA0lQ4130_assertion description "[Increased CF6 may be responsible in part for decreased prostacyclin observed in coronary heart disease, in particular after PTCA and stent therapy/risk factor for coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194585.RAFwuqVAXnC8gMp0_73hpiSy_C2QZ-CUS2KCflkdA0lQ4130_provenance.